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Abstract: A i m s: Gestational diabetes mellitus (GDM) is an emerging worldwide problem. Changes in 
clinical characteristics of women affected by GDM in a long-term perspective are still not properly 
investigated. We aimed to examine such changes over a decade in a retrospective single-center analysis. 
M e t h o d s: The medical documentation from Department of Metabolic Diseases, Krakow, Poland was 
analyzed. We included 633 women consecutively diagnosed with GDM in one of three time intervals: 
2007–2008 (N = 157), 2012–2013 (N = 272), 2016–2017 (N = 234). Statistical analyses were performed. 
R e s u l t s: Comparison of the three groups identified differences in the mean age of women at the GDM 
diagnosis (30.7 ± 5.0 years vs. 31.2 ± 4.7 vs. 32.5 ± 4.7, respectively, starting from the earliest 2007–2008 
group), pregnancy week at GDM diagnosis (28.0 ± 5.3 wks. vs. 25.9 ± 4.9 vs. 23.4 ± 6.8), the proportion of 
women diagnosed before the 24th week of pregnancy (12.8% vs. 16.5% vs. 31.3%), and gestational weight 
gain (12.4 ± 5.0 kg vs. 10.4 ± 5.2 vs. 10.0 ± 5.7); (p = 0.001 or less for all comparisons). We also found 
differences for glucose values on fasting and at 2 hours with the highest (0 min) and lowest level (120 min) 
in the 2016–2017, respectively. Finally, a borderline difference for the weight, but not for BMI, was found 
(64.1 ± 14.1 kg vs. 66.2 ± 13.1 vs. 67.8 ± 15.6; p = 0.04). Differences were also identified in the post hoc 
analysis between cohorts.  
C o n c l u s i o n: This retrospective analysis illustrates changes in characteristics of women with GDM 
occurring over the period of decade in Poland. They likely result from both epidemiological trends and 
modifications of the WHO criteria for the GDM diagnosis.  
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Introduction 
Gestational diabetes (GDM) is an emerging health problem and one of the most 
common medical complications of pregnancy [1]. It constitutes a challenge for pro-
fessionals from the field of gynecology and obstetrics, diabetology, internal medicine, 
pediatrics and midwifery. Numerous scientific studies showed that hyperglycemia in 
pregnancy might adversely influence pregnancy and perinatal period affecting new-
borns’ and mothers’ health [reviewed in 1, 2]. GDM frequency increases worldwide; 
for example, over the last 15 years, the frequency of its diagnosis has almost doubled in 
some European countries resulting in much higher cost of health care [1, 3, 4]. This 
rise seems to be associated with several reasons. One of them is a modification of 
GDM diagnostic criteria [5]. Another group of factors is related to the objective 
epidemiological trends involving women in a reproductive age. First, there is the 
obesity epidemic caused by sedentary lifestyle and unhealthy diet, which is one of 
the main risk factors for GDM [6]. Additionally, women currently plan their mother-
hood later, what creates an additional risk of developing disorders of glucose meta-
bolism during pregnancy [7].  
There is ongoing debate concerning the criteria and algorithm of GDM diagnosis 
in the community of diabetologists and gynecologists worldwide. Of note, there are 
various diagnostic algorithms for GDM in different regions of the world. In some 
countries screening is limited only to women from the risk groups of GDM (obesity, 
age above 35 years, a history of GDM in a previous pregnancy, birth of macrosomic 
baby, miscarriages), while in the other ones universal testing is a long-term standard 
[1, 8, 9]. For example, in Poland, pregnancy screening for GDM has been universal 
since 1994 [9]. Additionally, over the last 25 years, the diagnostic criteria of GDM 
have been changed several times in many countries what have had an impact on the 
prevalence of this form of diabetes mellitus [9, 10]. The most substantial changes were 
made after the publication of the HAPO (Hyperglycemia and Adverse Pregnancy 
Outcome) study results on pregnant women with mild hypoglycemia [11]. As a result 
of this publication, the GDM WHO diagnostic criteria were substantially toughened 
in 2013 [12]. In Poland, the criteria for GDM diagnosis were modified in 2014 
following these changes introduced by WHO [13]. 
Specific data on changes in clinical characteristics of GDM patients from different 
populations in a long-term perspective, that seem inevitable in the light of the objec-
tive epidemiological trends and modifications of diagnostic criteria and algorithms, is 
scare. We aimed to examine changes in the clinical characteristics of women with 
GDM over the last decade in a retrospective single-center analysis from Poland. 
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Materials and Methods 
This is a retrospective observational analysis based on medical documentation (years: 
2007–2008, 2012–2013, 2016–2017) collected at the Outpatient Clinic in Department 
of Metabolic Diseases, University Hospital in Krakow, a tertiary reference center for 
pregnant women with diabetes in the Lesser Poland region. Medical data of all con-
secutive patients were collected from 3 time intervals depending on the years in which 
they were diagnosed and treated in our center (group I — 2007–2008, group — II 2012 
and 2013, group III — 2016–2017). This retrospective study was accepted by the local 
Bioethical Committee and the authorities of the University Hospital in Krakow.  
We gathered the following information from the medical records of women with 
GDM — age at GDM diagnosis, gestational week of diagnosis, anthropometric mea-
surements (weight and BMI before pregnancy), weight before delivery, gestational 
weight gain (GWG), glycemic data (fasting glucose level and oral glucose tolerance 
test at the GDM screening) (Table 1), treatment (diet or insulin) and family history of 
diabetes. GWG was calculated as a difference between the last measured pregestational 
body weight and the last weight recorded during outpatient pregnancy care. Addi-
tionally, we collected the information for the medical history (past miscarriages, 
delivery of baby over 4000 g, GDM in previous pregnancies) and existing comorbid-
ities (arterial hypertension, polycystic ovary syndrome, lipid abnormalities, asthma) 
with the exception of the earliest period 2007–2008 for which they were not available. 
Women included in the analysis met the diagnostic criteria of GDM applicable in 
Poland for the year of diagnosis (Table 1).  
Table 1. Diagnostic GDM criteria in Poland over the study period. 
Venous plasma glucos  
(at least one criterion  
must be met) 
Group 2016–2017 Group 2012–2013  and 2007–2008 
Fasting glucose level 92–125 mg/dl   
(5.1–6.9 mmol/l) 
100–125 mg/dl  
(5.6–6.9 mmol/l) 
OGTT 75g 60’ ≥180 mg/dl  
(≥10 mmol/l) 
— 
OGTT 75g 120’ 153–199 mg/dl  
(8.5–11 mmol/l) 
≥140 mg/dl  
(≥7.8 mmol/l) 
one hour oral glucose  
challenge test (GCT) 
3rd trimester  
—  ≥200 mg/dl (≥11.2 mmol/l) 
141–199 mg/d (7.8–11.1 mmol/l)–>OGTT 75 g  
Pregnancy screening in Poland is universal since 1994. It is recommended to perform the initial examination, usually 
fasting plasma glucose, at the pregnancy booking. Women with high risk of GDM are immediately referred to OGTT. 
The OGTT test is obligatory in the third trimester. Until 2014 GCT (glucose challenge test 50 g) was also acceptable as 
the first step test. 
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Patients were also divided into two groups: with a GDM diagnosis below 24th 
week of pregnancy and at or after 24th week of pregnancy. We used this a proxy for 
a GDM diagnosis made at either the initial or 24th week of pregnancy screening as the 
Polish Diabetes Association clinical recommendations suggests that the second 
screening is done at the 24th week of pregnancy or in subsequent weeks. The follow-
ing variables were compared in this sub-analysis: age at GDM diagnosis, BMI as well 
as fasting and 2-hour glucose level. 
The statistical analysis was performed in R ver 3.6.1. Shapiro–Wilk test was used to 
test the normality of the data. Chi Square test was used to test relationships between 
categorical variables. To compare three independent time intervals ANOVA or Krus-
kal–Wallis test was used. To calculate pairwise comparisons between group levels with 
corrections for multiple testing pairwaise (Bonferoni) pairwise.wilcox.test was used. 
Based on the statistical data, a trend line model with a coefficient of determination 
(R2) was determined for individual variables.  
Results 
Overall, we analyzed 633 women with GDM who were consecutively diagnosed within 
three time intervals — 2007–2008 (N = 157), 2012–2013 (N = 272) and 2016–2017 
(N = 234). The clinical characteristics of the defined groups of patients are described 
in Table 2. 





(N = 157) 
Group II 
(2012–2013  




(N = 234) 
P value* 
Group I  
vs. III  
p value 
Group II  
vs. III  
p value 
Group I  
vs. II  
p value 
Age at GDM diagno-
sis mean ± SD [years] 
30.7 ± 5.0 31.1 ± 4.7 32.6 ± 4.7 <0.0001 0.0008 0.0014 <0.0001 
Body weight before 
pregnancy mean ± SD 
[kg] 
64.1 ± 14.1 66.2 ± 13.2 67.8 ± 15.6 0.04 0.07 1.0 0.1 
Prepregnancy BMI 
mean ± SD [kg/m2] 
23.7 ± 4.7 24.3 ± 4.5 24.9 ± 5.5 0.2    
GWG mean ± SD [kg] 12.4 ± 5.0 10.4 ± 5.1 10 ± 5.7 <0.0001 <0.0001 0.7 0.0004 
Week of pregnancy at 
the last pre-delivery 
visit mean ± SD 
[weeks] 
34.1 ± 3.5 34.4 ± 3.3 33.9 ± 4.0 0.2    
Week of pregnancy at 
GDM diagnosis mean 
± SD [weeks] 
28 ± 5.3 25.9 ± 4.9 23.4 ± 6.9 <0.0001 <0.0001 0.0004 <0.0001 
22 Magdalena Wilk, Katarzyna Cyganek, et al.  
A comparative analysis of the three groups identified differences in the mean age 
of women at the GDM diagnosis (30.7 ± 5.0 years vs. 31.2 ± 4.7 vs. 32.5 ± 4.7, 
respectively, starting from the earliest group), pregnancy week at GDM diagnosis 
(28.0 ± 5.3 wks. vs. 25.9 ± 4.9 vs. 23.4 ± 6.8), the proportion of women diagnosed 
before the 24th week of pregnancy (12.8% vs. 16.5% vs. 31.3%), and GWG (12.4 ± 
5.0 kg vs. 10.4 ± 5.2 vs. 10.0 ± 5.7); (p = 0.001 or less for all comparisons). Addition-
ally, we also found differences for glucose values on fasting and at 2 hours with the 
highest (0 min) and lowest (120 min) level in the 2016–2017 group, respectively. 
Finally, a borderline difference for the weight, but not for BMI, was found (64.1 ± 
GDM diagnosis before 
24 weeks of pregnancy 
[N, %] 
20 (12.8%) 45 (16.5%) 73 (31.3%) <0.0001 <0.0001 0.3 <0.0001 
GDM diagnosis at or 
after 24 weeks of 
pregnancy [N, (%)] 
137 (87.2%) 227 (83.5%) 161 (68.7%) <0.0001 <0.0001 <0.0001 0.3 
Insulin treatment  
[N, (%)] 
77 (49.0%) 108 (39.7%) 112 (47.9%) 0.1    
Glucose level in 
OGTT 0 min mean  
± SD [mmol/l] 
4.7 ± 0.7 4.7 ± 0.7  5.0 ± 0.6 <0.0001 0.0003 <0.0001 1.0 
Glucose level in 
OGTT 120 min mean 
± SD [mmol/l] 
8.9 ± 1.3 8.9 ± 1.4 8.3 ± 1.6 <0.0001 0.0004 <0.0001 1.0 
Diabetes family  
history [N, (%)] 
83 (58.9%) 153 (56.3%) 141 (60.8%) 0.7    
GDM in a previous 
pregnancy [N, (%)] 
No data 48 (17.7%) 43 (18.4%) 1.0 — — — 
Past miscarriages  
[N, (%)] 
No data 57 (20%) 46 (19.7%) 0.7 — — — 
History of delivery of 
baby over 4000 g  
[N, (%)] 
No data 19 (7%) 25 (10.7%) 0.1 — — — 
Hypertension [N, (%)] No data 26 (9.6%) 13 (5.6%) 0.2 — — — 
Lipid disorders  
[N, (%)] 
No data 2 (0.7%) 3 (1.3%) 0.8 — — — 
Asthma [N, (%)] No data 6 (2.2%) 4 (1.7%) 0.7 — — — 
Polycystic ovary syn-
drome [N, (%)] 
No data 3 (1.1%) 8 (3.4%) 0.2 — — —   
Data are presented as mean and standard deviation (SD). For categorical variable numbers and percentage were used. 
*P-value derived from one-way analysis of variance (ANOVA) or Kruskal–Wallis test to detect a significant difference 
in the variable levels among study groups. 
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14.1 kg vs. 66.2 ± 13.1 vs. 67.8 ± 15.6; p <0.04). Interestingly, there was no significant 
difference for the insulin treatment between the analysed groups. Similarly, compar-
ing the data on the patient’s medical history, no differences were noted in diabetes 
family history, history of miscarriages, childbirth above 4000 g, GDM in previous 
pregnancy and comorbidities.  
Plural differences were also identified between the cohorts in the post hoc analysis, 
that was performed for variables with significant discrepancies in the Anova analysis. 
First, we compared the 2007–2008 and 2012–2013 groups. Of note, for these two 
groups the same diagnostic criteria for GDM and algorithm were used (Table 1). In 
spite of this, we observed differences in age at diagnosis, gestational age at the GDM 
diagnosis, proportion of diagnosis before the 24th week of pregnancy and GWG. 
In the second set of post-hoc analysis, the group treated in 2016–2017 as com-
pared to the earliest 2007–2008 cohort was older at the time of GDM diagnosis, had 
a higher pre-gestational body weight and earlier GDM diagnosis during pregnancy as 
well as a higher proportion of GDM diagnosis made before 24 weeks of pregnancy and 
lower GWG. The groups also differed in terms of both analyzed glucose values as the 
fasting glucose level was lower and 2-hour higher in the earlier cohort.  
Finally, the group treated in 2016–2017 in comparison to the 2012–2013 cohort 
was characterized by an older age at GDM diagnosis, earlier diagnosis of GDM during 
gestation with a higher proportion of diagnosis made before the 24th week of gesta-
tion and by a lower GWG. This very recent group was also characterized by a higher 
fasting and lower 2-hour glucose level.  
We also compared the subgroups of women from the examined cohorts diagnosed 
before 24th week of pregnancy and at the 24th week or later as shown in Table 3. In 
the group of patients with GDM below 24 weeks of pregnancy differences were 
observed between the cohorts for BMI before pregnancy and 2-hours glucose level. 
Table 3. Selected clinical features of examined women from three cohorts as divided according to 
week (<24 and >24) of GDM diagnosis.  
2007–2008 
N = 157 
2012–2013 
N = 272 
2016–2017 
N = 234 
P  
value 
Women diagnosed before week 24 [N] 20 45 73  
Age at GDM diagnosis mean ± SD [years] 31.5 ± 5.0 30.6 ± 5.2 32.5 ± 4.9 0.2 
Prepregnancy BMI mean ± SD [kg/m2] 25.2 ± 6.4 24.6 ± 4.2 26.8 ± 6.8 0.0002 
Fasting glucose mean ± SD [mmol/l] 5.0 ± 1.1 5.0 ± 0.7 5.2 ± 0.6 0.1 
2 h glucose mean ± SD [mmol/l] 8.7 ± 1.1 7.9 ± 1.4 7.8 ± 1.8 0.004 
Proportion of GDM with pathological: 
— fasting glucose mean ± SD [N, (%)] 
— 1 h glucose mean ± SD [N, (%)] 
— 2 h glucose mean ± SD [N, (%)]  
6/17 (35.3%) 
No data 
9/17 (52.9%)  
12/38 (31.6%) 
No data 
26/41 (63.4%)  
41/68 (60.3%) 
23/64 (35.9%) 
26/66 (39.4%)  
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In the analysis for the sub-groups of women diagnosed with GDM at or after 24th 
week of pregnancy differences in age at the diagnosis and fasting glucose level in those 
groups were also observed. 
Discussion 
In this study, a retrospective analysis was conducted comparing the clinical character-
istics of patients with GDM diagnosed in three different time periods (2008–2009, 
2012–2013, 2016–2017). We report differences in several variables between the co-
horts and discuss the possible reasons for these observations. 
The age at GDM diagnosis was one of the variables with a significant difference 
between the groups with step-wise increase over the period of the analysis, i.e. 2007– 
2017. This probably reflects a more general trend of post-pone pregnancy planning 
that is observed in Poland and the other European countries [14, 15]. The situation is 
similar in many populations worldwide, for example, in the United States over the last 
50 years the proportion of pregnant women aged over 35 years has increased almost 
eight times [16]. Women report several different reasons for delaying childbearing, 
such as family situation, economic status, professional career being the priority, un-
awareness of the age impact on fertility [17]. Very similar results to ours showing 
a trend of increasing age in women diagnosed with GDM were also reported from the 
Asian population [18]. 
Another characteristic showing a difference between the three groups is time of 
GDM diagnosis during gestation which was getting earlier during the observation. 
This seems to be closely related to a significantly rising proportion of women with 
early diagnosis of GDM, defined in our study as <24th week of pregnancy. Of note, the 
proportion of women with early GDM diagnosis in our cohort increased 2.5 times 
Women diagnosed after week 24  N = 137  N = 227  N = 161  
Age at GDM diagnosis mean ± SD [years] 30.6 ± 5.0 31.3 ± 4.6 32.6 ± 4.5 0.001 
Prepregnancy BMI mean ± SD [kg/m2] 23.6 ± 4.5 24.3 ± 4.6 24.0 ± 4.5 0.4 
Fasting glucose mean ± SD [mmol/l] 4.6 ± 0.6 4.7 ± 0.7 5.0 ± 0.6 0.0001 
2 h glucose mean ± SD [mmol/l] 8.9 ± 1.3 8.8 ± 1.4 8.5 ± 1.5 0.3 
Proportion of GDM with pathological: 
— fasting glucose mean ± SD [N, (%)] 
— 1 h glucose mean ± SD [N, (%)] 
— 2 h glucose mean ± SD [N, (%)]  
20/126 (15.9%) 
No data 
72/137 (52.6%)  
46/224 (20.5%) 
No data 
118/224 (52.8%)  
52/157 (33.1%) 
71/148 (48.0%) 
94/156 (60.3%)   
Data are presented as mean and standard deviation (SD). For categorical variable numbers and percentage were used. 
*P-value derived from one-way analysis of variance (ANOVA) to detect a significant difference in the variable levels 
among study groups. 
For some number of women from the examined cohorts, the original glucose results used for GDM diagnosis were 
missing in the medical documentation. 
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over the study period. In Poland, the initial screening for GDM by the evaluation of 
fasting venous blood glucose level is advised at the first visit to the obstetricians during 
pregnancy. The oral glucose tolerance test is recommended at that time only for 
women at risk of GDM [13]. There are several possible reasons for the phenomenon 
observed by us in this study. One of them may be a growing patients’ and physicians’ 
awareness of the necessity of early screening. There is no formal assessment of such 
awareness in Poland among the medical staff available; however, the annual publica-
tion of the clinical recommendations by both the Polish Diabetes Association and the 
Polish Society of Gynecologists and Obstetricians as well as the full agreement reached 
by these organizations in terms of GDM criteria and diagnostic algorithm seem to be 
favorable factors for such increasing consciousness [13, 19]. This may result in a more 
frequent referral of patients to the OGTT test as an effect of more common classifying 
women as at-risk individuals. Finally, this growing proportion of early GDM diagnosis 
may be related to a rising number of women with pregestational diabetes, type 1 or 
type 2, being misdiagnosed as gestational form of disease [20].  
Another variable showing a significant difference between the three groups was 
GWG, interestingly presented as a gradual fall in the pregnancy weight gain over the 
study period. While this trend should be considered a desirable phenomenon, as the 
excessive GWG is a considerable risk factor of many pregnancy outcomes, such as 
large for gestational age (LGA) birth weight, macrosomia, and gestational hyperten-
sion [21], its reason in our study is unclear. Of note, larger values of pregestational 
BMI were found to be associated with a greater difficulty in maintaining adequate 
GWG [22]. A trend observed in our cohorts seems to go in an opposite direction as 
pregestational weight and BMI tended to go slightly up. The possible explanation may 
be a sooner dietary intervention related to the earlier GDM diagnosis in consecutive 
cohorts introduced in the tertiary center. The impact of growing awareness and 
efficacy of this dietary intervention cannot be also excluded.  
Changes in pre-pregnancy weight and BMI were both borderline, although a ten-
dency of rise for both variables were observed. Of note, none of the cohorts reached 
the formal cut-off for overweight. Our data and observed trend are very similar to 
some other populations, for example, in Australia and New Zealand between 1997 and 
2016 the mean pregnancy booking-in BMI climbed from 24.9 to 25.3 in 2012 before 
rising to 25.6 in 2016 [23]. The almost doubling of the incidence of GDM in the 
United States between 1978 and 2010 is mainly being explained by the increase in BMI 
in this population [24]. The observed worldwide increase in BMI among patients with 
diagnosed GDM is related to the population trend of growing obesity, but also parallel 
phenomenon of older age of getting pregnant [25].  
Finally, we identified differences in glucose levels, both fasting and 2-hour, be-
tween the three cohorts. In the post hoc analysis, the latest 2016–2017 cohort showed 
differences as compared to both earlier groups, that were similar to each other in 
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terms of glucose. While this is an expected observation taking into account the change 
in GDM diagnostic criteria and algorithm that occurred in Poland in 2014, the direc-
tion of these differences is surprising. The modification of GDM glycemic criteria 
resulting from the HAPO study decreased the fasting cut-off point from 100 mg/dL to 
92 mg/dL and increased the 2-hour glucose level from 140 mg/dL to 153 mg/dL 
[12, 13]. Thus, one should expect a fall of fasting glucose level and a rise in post-
-challenge one. Both changes in our study unexpectedly showed an opposite direction. 
One can speculate that this is a secondary phenomenon related to significant differ-
ences in age, pregnancy weeks of GDM diagnosis as well as borderline discrepancies in 
body mass.  
The limitation of this study is its observational, retrospective character, relatively 
small size of the investigated groups and difficulty in extrapolating the results of the 
study outside of the Polish population, because the algorithm and criteria for GDM 
diagnosis are not universal worldwide. However, it is worth pointing out that there are 
very few studies on the time change in characteristics of the GDM pregnant women. 
The differences described above are very likely to be a global phenomenon. Finally, we 
should acknowledge, that we were not able to include in this study delivery and 
neonatal outcomes, such as macrosomia, congenital defects, perinatal injuries and 
many others.  
In conclusion, this retrospective analysis revealed significant changes in charac-
teristics of women with GDM occurring over the period of decade in Poland. They 
probably result from both epidemiological trends, for example related to social factors 
such as later age of pregnancy and increase in obesity in society, as well as modifica-
tions of the local recommendations for the GDM diagnosis.  
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